entX
An innovation hub specializing in nuclear science and engineering to develop long-term power systems, life-saving medical isotopes, and clean energy technologies for space, defense, and healthcare.
- CEO / Founder
- Bryn Jones
- Team Size
- 10-50
- Stage
- Transitioning from laboratory prototypes to pre-production and industrial demonstration; flight heritage missions for RPS technologies targeted for 2026-2027.
- Total Funding
- $27.0M
- Latest Round
- CRC-P Grant
- Key Investors
- ["Foxglove Capital","Australian Government (Department of Industry, Science and Resources)","Private Investors"]
Technology & Products
Key Products
["GenX Betavoltaic Power Generator (long-life nuclear battery)","IsoMedica (extraction and purification of medical isotopes like Pb-212, Radium, and Thorium)","Radioisotope Heating Unit (RHU) for lunar and deep space missions","PhosEnergy Process (uranium extraction from phosphate fertilizer streams)","CarbonX (betacatalysis technology for carbon transition)","Green Hydrogen and Ammonia supply projects (Western Eyre & Kimberly-Clark)"]
Technological Advantage
Utilizes proprietary semiconductor deposition and additive manufacturing (3D printing) to integrate radioactive layers into compact frames, significantly increasing energy density compared to traditional methods. Also features the ability to recover valuable isotopes from unconventional sources like mine tailings and waste streams.
Market & Competition
Target Customers
Space agencies (e.g., ASA, NASA), defense contractors, global radiopharmaceutical companies, and heavy industrial firms seeking decarbonization solutions.
Industry Verticals
["Space & Aerospace","Defense","Healthcare (Nuclear Medicine)","Clean Energy","Heavy Industry & Mining"]
Competitors
["City Labs","Arkenlight","SHINE Technologies","Betavolt"]